Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Non-Current Debt (2020 - 2026)

Orthofix Medical has reported Non-Current Debt over the past 10 years, most recently at $221.3 million for Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Debt rose 41.08% year-over-year to $221.3 million, compared with a TTM value of $221.3 million through Mar 2026, up 41.08%, and an annual FY2025 reading of $157.4 million, changed 0.24% over the prior year.
  • Non-Current Debt came in at $221.3 million for Q1 2026, up from $157.4 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $221.3 million in Q1 2026 to a low of $45.0 million in Q1 2023.
  • Median Non-Current Debt over the past 4 years was $115.1 million (2024), compared with a mean of $123.6 million.
  • The sharpest move saw Non-Current Debt soared 155.71% in 2024, then increased 0.24% in 2025.
  • Over 4 years, Non-Current Debt stood at $93.1 million in 2023, then soared by 68.64% to $157.0 million in 2024, then increased by 0.24% to $157.4 million in 2025, then skyrocketed by 40.63% to $221.3 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Non-Current Debt are $221.3 million (Q1 2026), $157.4 million (Q4 2025), and $157.2 million (Q3 2025).